Accuray Incorporated (ARAY) vs Metagenomi, Inc. Common Stock (MGX)

A side-by-side comparison of Accuray Incorporated and Metagenomi, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Accuray Incorporated logo
ARAY
Accuray Incorporated
$33M
$0.28HealthcareDelayed quote: Oct 6, 2026, 2:30 PM EDT
Metagenomi, Inc. Common Stock logo
MGX
Metagenomi, Inc. Common Stock
$39M
$1.04HealthcareDelayed quote: Oct 6, 2026, 2:24 PM EDT

Total return — ARAY vs MGX

growth of $100 · dividends reinvested · last 3y
ARAY -88.6% (-51.5%/yr)MGX -89.9% (-53.4%/yr)ARAY compounded faster over this window
050100Start $10020252026$11$10
ARAY MGX

ARAY vs MGX: by the numbers

  • •MGX is the larger company ($39M vs $33M market cap).
  • •Both run net losses; ARAY's is the smaller (-12.24% vs -689.20% net margin).

Metrics side by side

Valuation

MetricARAYMGX
P/S ratio0.082.89
P/B ratio0.800.35

Profitability

MetricARAYMGX
Gross margin27.73%74.29%
Operating margin-6.58%-380.85%
Net margin-12.24%-689.20%
ROE-117.97%-83.03%
ROIC-10.09%-66.03%

Growth (annualized)

MetricARAYMGX
Revenue CAGR (5Y)0.28%N/A
Total return CAGR (5Y)-39.94%N/A

Go deeper

Full ARAY analysisFull MGX analysisInteractive comparison tool

Dig into the metrics

Accuray ROEMetagenomi, Inc. Common Stock ROEAccuray operating marginMetagenomi, Inc. Common Stock operating marginAccuray revenue growthMetagenomi, Inc. Common Stock revenue growthAccuray free cash flowMetagenomi, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.